Company / SG&A Expense
Sabra Health Care REIT SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$53.7M
FY2025
5-year range
$34.7M / $53.7M
FY2021-FY2025
Trend
+7.3%
vs FY2024
Sector context
#69 of 131
Real Estate
What the data says
At $54M, Sabra Health Care REIT's sg&a expense ranks #63 of 131 in the Real Estate sector. SG&A Expense has increased for 6 consecutive years, from $31M in FY2019 to $54M in FY2025.
Based on SEC 10-K filings.
$54M in FY2025 with a 5-year CAGR of +10.4%.
Increased from $47M to $54M over the past 2 years.
Real Estate sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +10.7%
- 5-Year CAGR
- +10.4%
- 10-Year CAGR
- -
Sector benchmark
#63 of 131 in Real EstateTop 47% of 131This company $53.7M Sector average $159.5M
▼
-66.3% below sector average
Key checks
Key Insights
- Sabra Health Care REIT's sg&a expense has grown for 6 consecutive years.
- 5-year CAGR of +10.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 7.3% year-over-year.
- Ranks #69 out of 131 companies in the Real Estate sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $53.7M | +7.3% |
| FY2024 | $50.1M | +5.5% |
| FY2023 | $47.5M | +20.0% |
| FY2022 | $39.6M | +14.1% |
| FY2021 | $34.7M | +5.8% |
| FY2020 | $32.8M | +6.1% |
| FY2019 | $30.9M | -16.7% |
| FY2018 | $37.1M | +14.5% |
| FY2017 | $32.4M | +83.3% |
| FY2016 | $17.7M | +9.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026